A phase II, multicentre, randomised, double-blind, parallel groups, placebo controlled clinical study of efficacy and safety of Dysport [botulinum toxin A] for migraine prophylaxis.

Trial Profile

A phase II, multicentre, randomised, double-blind, parallel groups, placebo controlled clinical study of efficacy and safety of Dysport [botulinum toxin A] for migraine prophylaxis.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Nov 2009

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors Ipsen
  • Most Recent Events

    • 12 Sep 2007 Status changed from in progress to completed.
    • 05 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top